- MRI Scanner

MRIs and ICDs can mix, at least if MR imaging is with a 1.5 Tesla machine and the implantable cardioverter-defibrillator system is the one tested in a late-breaking clinical trial presented May 14 at the Heart Rhythm Society’s scientific session in Boston.

 - No radiation

The use of myocardial perfusion imaging (MPI) has spiked over the past four decades and along with it individual patient dose. A comprehensive effort to reduce that dose could reduce unnecessary procedures and reduce the risk of downstream cancers, according to a meta-analysis published in the April issue of the Journal of Nuclear Medicine.

 - Brain, neuro, carotid stenting

High-grade astrocytoma is a particularly aggressive form of glioma. Parameters of PET imaging such as the minimal time-to-peak could help clinicians narrow in on the best line of treatment for each patient, according to a study published Dec. 23 in the Journal of Nuclear Medicine.

 - LDCT Lung Cancer Screening

A quantitative PET measurement known as total lesion glycolysis could help clinicians make informed prognoses for patients with a stage of non-small lung cancer, according to a study published online Dec. 18 in the Journal of Nuclear Medicine.

 - Full Body Nuclear medicine

The global market for nuclear imaging technology is forecasted to reach $2.2 billion in 2020, just a 3.3 percent compound annual growth rate over the $1.83 billion noted for 2013, according to a December 2014 report by GlobalData.